Behavioral
Horizon Behavioral Health, P.C.
Horizon Behavioral Health, P.C. was paid $1.01M by Medicaid between Jan 2018 and Oct 2023, across 22 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 18% of everything it billed.
33Billing provider infoHORIZON BEHAVIORAL HEALTH, P.C.
HINESVILLE, GA 31313
HINESVILLE, GA 31313
33aNPI1891003299assigned 09/20/2010
33bProvider typePsychologist
28Total paid$1.01M
24GClaims23,489
24DCodes billed22
24AFirst – last monthJan 2018 – Oct 2023
Compared with peers
Next to other Psychologist providers in Georgia
Rank by total paid#2 of 24
Median peer was paid$20K
This provider vs. median49×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,630 | $420K | |
| 2019 | 9,720 | $458K | |
| 2020 | 3,689 | $117K | |
| 2021 | 939 | $3K | |
| 2022 | 411 | $4K | |
| 2023 | 100 | $10K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 18% | 3,155 | 3,072 | $184K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 3,869 | 3,776 | $144K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 3,498 | 3,082 | $128K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 12% | 1,097 | 1,058 | $127K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 8.8% | 704 | 684 | $89K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 7.0% | 2,222 | 2,100 | $71K |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 4.3% | 539 | 485 | $44K |
| 99205 | Prolong outpt/office vis | 3.9% | 341 | 326 | $40K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.9% | 419 | 414 | $39K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 3.9% | 587 | 582 | $39K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 3.1% | 463 | 391 | $32K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.9% | 245 | 229 | $19K |
10 more codes
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 1.3% | 86 | $13K |
| 96127 | 1.1% | 4,316 | $11K | |
| 96101 | <1% | 66 | $10K | |
| 96130 | <1% | 120 | $7K | |
| 96131 | <1% | 78 | $7K | |
| 81025 | <1% | 772 | $5K | |
| 96136 | <1% | 44 | $1K | |
| 96137 | <1% | 31 | $1K | |
| 90785 | <1% | 802 | $1K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 35 | $273.20 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBANJOKO, AFOLARIN (PHYSICIAN/OWNER)
| Provider | Location | Paid |
|---|---|---|
| Horizon Diagnostic Laboratory | Hinesville, GA | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.